JP2023518529A5 - - Google Patents
Info
- Publication number
- JP2023518529A5 JP2023518529A5 JP2022558331A JP2022558331A JP2023518529A5 JP 2023518529 A5 JP2023518529 A5 JP 2023518529A5 JP 2022558331 A JP2022558331 A JP 2022558331A JP 2022558331 A JP2022558331 A JP 2022558331A JP 2023518529 A5 JP2023518529 A5 JP 2023518529A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- compound
- solid dispersion
- alkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062993775P | 2020-03-24 | 2020-03-24 | |
| US62/993,775 | 2020-03-24 | ||
| PCT/CA2021/050385 WO2021189141A1 (en) | 2020-03-24 | 2021-03-24 | Solid dispersions of amorphous 3, 4-diphenyl-4, 5-dihydro- 1h-pyrazole derivatives, compositions comprising them and uses thereof as cannabinoid cb1 receptor inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023518529A JP2023518529A (ja) | 2023-05-01 |
| JP2023518529A5 true JP2023518529A5 (https=) | 2024-02-27 |
Family
ID=77890104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558331A Pending JP2023518529A (ja) | 2020-03-24 | 2021-03-24 | 非晶質３，４－ジフェニル－４，５－ジヒドロ－１ｈ－ピラゾール誘導体の固体分散体、それを含む組成物及びカンナビノイドｃｂ１受容体阻害剤としてのその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230174493A1 (https=) |
| EP (1) | EP4126822A4 (https=) |
| JP (1) | JP2023518529A (https=) |
| KR (1) | KR20220156930A (https=) |
| CN (1) | CN115335361A (https=) |
| AU (1) | AU2021242808A1 (https=) |
| CA (1) | CA3169753A1 (https=) |
| MX (1) | MX2022011899A (https=) |
| WO (1) | WO2021189141A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4482490A4 (en) * | 2022-02-24 | 2025-08-20 | Novo Nordisk As | METHODS OF TREATING SUBJECTS WITH HYPERTRIGLYCERIDEMIA, ABDOMINAL OBESITY AND/OR ALTERED GLUCOSE |
| WO2025040089A1 (zh) * | 2023-08-21 | 2025-02-27 | 德睿智药(苏州)新药研发有限公司 | 用于选择性调节大麻素cb1功能的新型杂环类化合物 |
| WO2025103493A1 (zh) * | 2023-11-16 | 2025-05-22 | 西藏海思科制药有限公司 | 一种大麻素受体1拮抗剂及其应用 |
| WO2025257151A1 (en) | 2024-06-10 | 2025-12-18 | Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical composition for treating ciliopathies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2083799A1 (en) * | 2006-10-20 | 2009-08-05 | Solvay Pharmaceuticals B.V. | Micellar nanoparticles of chemical substances |
| CN104884057B (zh) * | 2012-11-13 | 2019-08-20 | 美国政府(由卫生和人类服务部的部长所代表) | 大麻素受体介导的化合物 |
| CA2955510C (en) * | 2014-07-25 | 2018-09-04 | Allen-Vanguard Corporation | System and method for ultra wideband radio frequency scanning and signal generation |
| WO2016196646A1 (en) * | 2015-06-04 | 2016-12-08 | The United States Of America, As Represented By The Secretary, Departmet Of Health & Human Services | Cannabinoid receptor mediating compounds |
| US12286405B2 (en) * | 2019-05-17 | 2025-04-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase |
-
2021
- 2021-03-24 US US17/913,292 patent/US20230174493A1/en active Pending
- 2021-03-24 MX MX2022011899A patent/MX2022011899A/es unknown
- 2021-03-24 EP EP21774577.7A patent/EP4126822A4/en active Pending
- 2021-03-24 CN CN202180024137.9A patent/CN115335361A/zh active Pending
- 2021-03-24 JP JP2022558331A patent/JP2023518529A/ja active Pending
- 2021-03-24 AU AU2021242808A patent/AU2021242808A1/en active Pending
- 2021-03-24 CA CA3169753A patent/CA3169753A1/en active Pending
- 2021-03-24 KR KR1020227036821A patent/KR20220156930A/ko active Pending
- 2021-03-24 WO PCT/CA2021/050385 patent/WO2021189141A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023518529A5 (https=) | ||
| JP5916752B2 (ja) | ５−クロロ−ｎ２−（２−イソプロポキシ−５−メチル−４−ピペリジン−４−イル−フェニル）−ｎ４［２−（プロパン−２−スルホニル）−フェニル］−ピリミジン−２，４−ジアミンの結晶形 | |
| CN101243066B (zh) | 甲磺酸伊马替尼的δ和ε晶形 | |
| CN103221035A (zh) | C-met调节剂药物组合物 | |
| CN102827153B (zh) | 阿齐沙坦的晶型及其制备方法 | |
| WO2014008794A1 (zh) | 一种酪氨酸激酶抑制剂的二马来酸盐的i型结晶及制备方法 | |
| EP3229791A2 (en) | Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof | |
| KR101266587B1 (ko) | 조직 인자 생성 억제제 | |
| CN104098570A (zh) | 替卡格雷晶型及其制备方法和用途 | |
| CN104592195A (zh) | 一种苯甲酸阿格列汀的制备方法 | |
| JP2011520928A (ja) | キナゾリン誘導体を含む組成物、その調製方法及び使用 | |
| CN101277694B (zh) | 盐酸伊立替康的新晶形 | |
| JP2016536321A (ja) | カナグリフロジンのｂ形結晶、ｃ形およびｄ形 | |
| JP2014516921A (ja) | 混晶アゴメラチン（ｖｉｉｉ型）、その調製方法及び使用、並びにこれを含有する医薬組成物 | |
| CN101774937B (zh) | N-[2-(7-甲氧基-1-萘基)乙基]乙酰胺及其组合物 | |
| CN101066267B (zh) | 一种含有阿立哌唑微晶的固体口服药物组合物 | |
| CN103232443B (zh) | 一种吲唑衍生物的晶型及其制备和用途 | |
| WO2022268063A1 (zh) | 嘧啶类衍生物的晶型及其制备方法 | |
| JP6945024B2 (ja) | 固形医薬組成物 | |
| JP6130595B2 (ja) | ピロロキノリンキノンリチウム塩の結晶体及び調製方法と応用 | |
| CN110256373A (zh) | 一种小粒度盐酸阿考替胺结晶的制备方法 | |
| WO2021097650A1 (zh) | 奥利司他与氨基酸的共晶体及包含该共晶体的药物组合物 | |
| JP2019509314A (ja) | Ｄｐｐｉｖ阻害剤の塩形態およびその製造方法 | |
| CN101792385B (zh) | 索法酮的晶型ⅷ及其制备方法和用途 | |
| CN101817742B (zh) | 索法酮的晶型ⅹ及其制备方法和用途 |